ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effects of Shenkang Pills on Early-Stage Diabetic Nephropathy in db/db Mice via Inhibiting AURKB/RacGAP1/RhoA Signaling Pathway

Wang, Fujing; Fan, Jia'er; Pei, Tingting; He, Zhuo'en; Zhang, Jiaxing; Ju, Liliang; Han, Zhongxiao; Wang, Mingqing*; Xiao, Wei*南方医科大学
Frontiers in Pharmacology2022-2-11DOI: 10.3389/fphar.2022.781806
5被引20阅读
引用收藏
分享

摘要

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, so there is an urgent need to suppress its development at early stage. Shenkang pills (SKP) are a hospital prescription selected and optimized from effective traditional Chinese medicinal formulas for clinical treatment of DN. In the present study, liquid chromatography-quadrupole-time of flight-mass spectrometry (LC-Q-TOF-MS) and total contents qualification were applied to generate a quality control standard of SKP. For verifying the therapeutic effects of SKP, db/db mice were administered intragastrically with SKP at a human-equivalent dose (1.82 g/kg) for 4 weeks. Moreover, the underlying mechanism of SKP were analyzed by the renal RNA sequencing and network pharmacology. LC-Q-TOF-MS identified 46 compounds in SKP. The total polysaccharide and organic acid content in SKP were 4.60 and 0.11 mg/ml, respectively, while the total flavonoid, saponin, and protein content were 0.25, 0.31, and 0.42 mg/ml, respectively. Treatment of SKP significantly reduced fasting blood glucose, improved renal function, and ameliorated glomerulosclerosis and focal foot processes effacement in db/db mice. In addition, SKP protected podocytes from injury by increasing nephrin and podocin expression. Furthermore, transcriptome analyses revealed that 430 and 288 genes were up and down-regulated in mice treated with SKP, relative to untreated controls. Gene ontology enrichment analysis revealed that the differentially expressed genes mainly involved in modulation of cell division and chromosome segregation. Weighted gene co-expression network analysis and network pharmacology analysis indicated that aurora kinase B (AURKB), Rac GTPase activating protein 1 (RacGAP1) and SHC binding, and spindle associated 1 (shcbp1) might be the core targets of SKP. This protein and Ras homolog family member A (RhoA) were found overexpression in db/db mice, but significantly decreased with SKP treatment. We conclude that SKP can effectively treat early-stage DN and improve renal podocyte dysfunction. The mechanism may involve down-regulation of the AURKB/RacGAP1/RhoA pathway.

学科与关键词

关键词
diabetic nephropathyshenkang pillsLCMStranscriptomeAURKBRacGAP1RhoA
相关
加载中…
  • SKP alleviates the ferroptosis in diabetic kidney disease through suppression of HIF-1α/HO-1 pathway based on network pharmacology analysis and experimental validation
    Yan, Yangtian; Yuan, Ningning; Chen, Yuchi; Ma, Yun; Chen, Ali; Wang, Fujing; Yan, Shihua; He, Zhuo'en; He, Jinyue; Zhang, Chi; Wang, Hao; Wang, Mingqing*; Diao, Jianxin*; Xiao, Wei*Chinese Medicine, 2024, 19(1): 31.
  • Network Pharmacology-Based Investigation of the Molecular Mechanisms of the Chinese Herbal Formula Shenyi in the Treatment of Diabetic Nephropathy
    Chen, Keng; Deng, Yiyao; Shang, Shunlai; Li, Ping; Liu, Linchang*; Chen, Xiangmei*Frontiers in Medicine, 2022, 9: 898624.被引 2
  • Uncovering the mechanism of Qidan Dihuang Granule in the treatment of diabetic kidney disease combined network pharmacology, UHPLC-MS/MS with experimental validation
    Xiang, Lei*; Cai, Xiangsheng; Zhao, Xiaoshan; Liu, Yuanling; Xiao, Ya; Jiang, Pingping; Yin, Lianghong*; Song, Dan*; Jiang, Xuefeng*Heliyon, 2023, 9(11): e21714.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-02-11
卷期
第 13 卷
页码
781806
DOI
10.3389/fphar.2022.781806
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Foundation for Natural Scientific Research of China [82174322, 82004336, 82104795]; Natural Science Foundation of Guangdong Province, China [2017A030313750]; Science Research program of Guangzhou, China [201804010478]

作者

  • W

    Wang, Fujing (第一作者)

    southern med univ

  • F

    Fan, Jia'er

    southern med univ

查看全部 9 位作者收起作者
  • P

    Pei, Tingting

    southern med univ

  • H

    He, Zhuo'en

    southern med univ

  • Z

    Zhang, Jiaxing

    southern med univ

  • J

    Ju, Liliang

    southern med univ

  • H

    Han, Zhongxiao

    southern med univ

  • W

    Wang, Mingqing (通讯)

    southern med univ

  • X

    Xiao, Wei (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417